ATE301472T1 - Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung - Google Patents

Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung

Info

Publication number
ATE301472T1
ATE301472T1 AT95916149T AT95916149T ATE301472T1 AT E301472 T1 ATE301472 T1 AT E301472T1 AT 95916149 T AT95916149 T AT 95916149T AT 95916149 T AT95916149 T AT 95916149T AT E301472 T1 ATE301472 T1 AT E301472T1
Authority
AT
Austria
Prior art keywords
therapeutic
growth factors
containing growth
homeopathic dilutions
dilutions containing
Prior art date
Application number
AT95916149T
Other languages
English (en)
Inventor
Barbara A Brewitt
Original Assignee
Biomed Comm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomed Comm Inc filed Critical Biomed Comm Inc
Application granted granted Critical
Publication of ATE301472T1 publication Critical patent/ATE301472T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95916149T 1994-03-31 1995-03-30 Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung ATE301472T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22136594A 1994-03-31 1994-03-31
PCT/US1995/003984 WO1995026679A1 (en) 1994-03-31 1995-03-30 Therapeutic homeopathic dilutions of growth factors and methods of their use

Publications (1)

Publication Number Publication Date
ATE301472T1 true ATE301472T1 (de) 2005-08-15

Family

ID=22827513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916149T ATE301472T1 (de) 1994-03-31 1995-03-30 Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung

Country Status (10)

Country Link
US (1) US5626617A (de)
EP (1) EP0776175B1 (de)
CN (1) CN1149822A (de)
AP (1) AP642A (de)
AT (1) ATE301472T1 (de)
AU (1) AU2275395A (de)
CA (1) CA2186392A1 (de)
DE (1) DE69534371T2 (de)
NZ (1) NZ284214A (de)
WO (1) WO1995026679A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858977A (en) * 1994-10-13 1999-01-12 Amgen Inc. Method of treating diabetes mellitus using KGF
IT1296342B1 (it) * 1997-11-24 1999-06-25 Biotekna Apparecchiatura elettromedicale
US6048301A (en) * 1998-07-13 2000-04-11 Sabuda; Thomas J. Method and device for stimulating biological processes
US6142927A (en) * 1998-09-14 2000-11-07 Clark; James Hoyt Method and apparatus for treatment with resonant signals
US6272383B1 (en) * 1999-06-28 2001-08-07 Woodside Biomedical, Inc. Electro-acupuncture method using an electrical stimulator
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
RU2217149C2 (ru) * 2002-01-08 2003-11-27 Кабардино-Балкарский государственный университет Гомеопатический препарат для лечения сахарного диабета второго типа
FR2887151B1 (fr) * 2005-06-20 2009-07-03 Lantenois Christian Marcel Gus Utilisation nouvelle d'une souche homeopathique pour la preparation de medicaments homeopathiques, actifs sur l'herpes, le zona, les verrues et sur les retrovirus de type rna
US8131355B2 (en) * 2007-08-01 2012-03-06 James Hoyt Clark Automated skin electrical resistance measurement device and method
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
TWI450707B (zh) 2010-11-09 2014-09-01 Univ Chung Hua 生物阻抗量測儀及生物阻抗量測儀組合
RU2013111962A (ru) * 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
AU2014262532B2 (en) * 2013-05-09 2019-08-22 Advanced Neuroregenerative Therapies, Llc G-CSF for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal
CN103937808B (zh) * 2014-03-05 2017-01-18 清华大学 一种重组家蚕素的表达方法及其抗肿瘤应用
WO2021188883A1 (en) * 2020-03-20 2021-09-23 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for the treatment of viral disease using granulocyte-macrophage colony-stimulating factor (gm-csf)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU797686A1 (ru) * 1977-10-03 1981-01-23 Предприятие П/Я А-7538 Устройство дл воздействи набиОлОгичЕСКи АКТиВНыЕ ТОчКи
FR2418646A1 (fr) * 1978-03-02 1979-09-28 Malatier Paul Appareil a utilisation therapeutique ayant une double fonction : la localisation electrique des points d'acupuncture et le traitement electrique de ces points
US4341762A (en) * 1981-04-07 1982-07-27 Haast William E Use of snake venoms for treatment of neurological and related disorders
GB2151489B (en) * 1981-09-24 1986-06-18 Richard Hugh Cameron Bentall Device for applying a high frequency electromagnetic field to living tissue to promote healing thereof
GB2128093B (en) * 1982-10-05 1986-03-05 Edwin Leonard Head An electrical therapy device
SU1289491A1 (ru) * 1983-12-05 1987-02-15 Отделение Медико-Биологических Проблем Электротехники Всесоюзного Научно-Исследовательского Проектно-Конструкторского И Технологического Института Кабельной Промышленности Способ лечени больных острыми средними отитами
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5168051A (en) * 1985-03-22 1992-12-01 Genentech, Inc. Nucleic acid encoding TGF-β its uses
US4989604A (en) * 1985-10-03 1991-02-05 Accu Science Corporation Electromagnetic device
CA1275922C (en) * 1985-11-28 1990-11-06 Harunobu Amagase Treatment of cancer
SU1538916A1 (ru) * 1986-01-06 1990-01-30 Одесский Научно-Исследовательский Институт Курортологии Способ лечени больных, перенесших вирусный гепатит в раннем периоде реконвалесценции
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
FR2597339A1 (fr) * 1986-04-16 1987-10-23 Bounan Michel Trois substances a activite antitumorale preparees par dilutions successives d'hormones vegetales de croissance.
US5000178A (en) * 1986-05-23 1991-03-19 Lti Biomedical, Inc. Shielded electromagnetic transducer
DE3817360A1 (de) * 1988-05-20 1989-11-30 Zoubek Eugen Arzneimittel
US5118791A (en) * 1989-05-25 1992-06-02 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
US5108989A (en) * 1990-04-04 1992-04-28 Genentech, Inc. Method of predisposing mammals to accelerated tissue repair
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
FR2695556B1 (fr) * 1992-09-15 1995-03-24 Rochas Sa Parfums Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.

Also Published As

Publication number Publication date
CN1149822A (zh) 1997-05-14
US5626617A (en) 1997-05-06
AP9600867A0 (en) 1996-10-31
DE69534371T2 (de) 2006-05-24
CA2186392A1 (en) 1995-10-12
AP642A (en) 1998-04-23
AU2275395A (en) 1995-10-23
EP0776175B1 (de) 2005-08-10
EP0776175A4 (de) 2001-02-21
NZ284214A (en) 1997-07-27
WO1995026679A1 (en) 1995-10-12
EP0776175A1 (de) 1997-06-04
DE69534371D1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
DE69704612D1 (de) Dentalmasse und dental-produkt
DE69719603D1 (de) Kosmetisches Haarwaschmittel und dessen Verwendung
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69629988D1 (de) Pharmazeutisches Grundbestandteil und seine Verwendung
ATE301472T1 (de) Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung
DE59306001D1 (de) Wirbelsäulenimplantat und Repositionsinstrument
DE69600048D1 (de) Kosmetisches Haarwaschmittel und dessen Verwendung
ATE186447T1 (de) Zusammensetzung und verwendung
DE69322807D1 (de) Zahnprothese und Herstellungsverfahren
DE69223465D1 (de) Polymere Zusammensetzungen und Verwendung derselben
DE69620270D1 (de) Backfett und dessen Verwendung
DE69726001D1 (de) Verminderung des haarwuchhses
EP1037641A4 (de) Köder des transkriptionsfaktors und tumorwachstumsinhibitor
DE69525446D1 (de) Flavanolderivate und haarnährmittel und sie enthaltende wachstumsfördernde zusammensetzung
DE69720053D1 (de) Verminderung des haarwuchses
DE69302234D1 (de) Menschliches Prohibitin und Prohibitin kodierende DNS
DE69333528D1 (de) D-n-carbamoylaminosaureamidohydrolase und hydantoinase
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69600829D1 (de) Mikrobizide Zusammensetzung und deren Verwendung
DE59307396D1 (de) Dichtring und verwendung desselben
DE4494231T1 (de) Therapeutische Zusammensetzung und ihre Anwendung
DE69508165D1 (de) Strickschlussteil und Schluss
GB9519710D0 (en) Treatment of particulate material
DE69629027D1 (de) Kosmetische zubereitung zur prävention und beseitigung von hautschäden
DE59207083D1 (de) Pyroelektrisches Keramikmaterial und dessen Verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties